TARA for Medical Students, a Single-arm Mixed Methods Pilot Study
Launched by UMEÅ UNIVERSITY · Sep 19, 2021
Trial Information
Current as of July 22, 2025
Completed
Keywords
ClinConnect Summary
The primary aim of this study was to investigate the feasibility and acceptability of TARA as indicated prevention of symptoms of depression and anxiety and stress-related symptoms in self-selected medical students. The investigators also aimed to qualitatively explore the students' experiences of participating in TARA both during and after the program as well as at a two-year follow-up. The study was designed as a single arm pre-post intervention study.
Participants and procedures Participants were recruited from Umeå University School of Medicine. The University is located in the north o...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Medical student at Umeå University in the second or fourth semester.
- Exclusion Criteria:
- • None.
About Umeå University
Umeå University, a leading research institution in Sweden, is dedicated to advancing healthcare through innovative clinical trials and translational research. With a strong emphasis on interdisciplinary collaboration, the university harnesses cutting-edge technology and expert knowledge across various fields to address critical health challenges. Its commitment to ethical standards and patient safety ensures that all clinical trials conducted under its auspices are designed to generate robust scientific evidence, ultimately contributing to improved health outcomes and informed medical practices. Umeå University strives to foster a dynamic research environment that supports the development of new therapies and enhances the understanding of complex health issues.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Umeå, Vasterbotten, Sweden
Patients applied
Trial Officials
Eva Henje, MD, PhD
Principal Investigator
Umeå University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials